Analysis of systemic inflammation on the link between periodontitis and glycaemic status

Summarised from:

Mediation analysis of systemic inflammation on the association between periodontitis and glycaemic status
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.12884)

Authors:

Kitti Torrungruang, Boonsong Ongphiphadhanakul, Supawadee Jitpakdeebordin, Somchai Sarujikumjornwatana

Summarised by:

Dr Varkha Rattu

Research Topic:

Background + Aims

  • Emerging evidence suggests that periodontitis may increase the risk of developing type 2 diabetes.
  • Cross-sectional studies, such as NHANES III in the US and KNHANES in Korea, have shown that periodontitis is associated with impaired fasting glucose and diabetes.
  • Several prospective studies have associated periodontitis with poorer glycaemic control or subsequent diabetes, although findings have not been consistent across all studies.
  • Inflammation may be a key mechanism linking periodontitis to diabetes, as elevated systemic inflammatory markers like C-reactive protein (CRP) and white blood cell count (WBC) have been observed in both conditions.
  • Research has begun to assess other inflammatory biomarkers, such as the neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR), which have been associated with diabetes in some studies, although their link to periodontitis remains unclear.
  • This study aims to investigate the relationship between periodontitis and impaired fasting glucose or diabetes in a Thai population and to explore whether CRP, WBC, NLR, and PLR mediate or modify these associations.

Materials + Methods

  • This cross-sectional study analysed data from the Electricity Generating Authority of Thailand (EGAT) cohort between June and November 2003.
  • Participants with ≥6 teeth and complete medical data were included, while those with conditions affecting inflammatory markers were excluded.
  • Medical history, sociodemographic data, and physical exams were collected.
  • Periodontal assessments, conducted by 6 calibrated periodontists, measured probing depth (PD) and clinical attachment level (CAL) at 6 sites per tooth.
  • Participants were categorised into no/mild, moderate, or severe periodontitis based on CDC/AAP definitions.
  • Glycaemic status was assessed using fasting plasma glucose (FPG) levels: normal (<100 mg/dl), impaired fasting glucose (≥100 but <126 mg/dl), or diabetes (≥126 mg/dl or on anti-diabetic medication).
  • Blood samples were analysed for WBC, CRP, NLR, and platelet–lymphocyte ratio (PLR).
  • CRP was measured using a high-sensitivity immunonephelometric assay.
  • Covariates included age, gender, education, smoking and drinking status, exercise, body mass index (BMI), family history of diabetes, hypercholesterolemia, and hypertension.
  • Multinomial logistic regression estimated the odds of IFG or diabetes versus normal glucose, comparing moderate and severe periodontitis with no/mild periodontitis and adjusting for potential confounders.
  • Mediation analyses examined each inflammatory biomarker separately, comparing severe periodontitis with combined no/mild and moderate periodontitis. Effect modification analyses tested whether associations differed according to biomarker levels.

Results

  • Of the 2,036 participants analysed:
    • IFG: 16.3%
    • Diagnosed with diabetes: 7.4%
  • Participants with diabetes were generally older, male, less educated, and had a higher prevalence of smoking, drinking, obesity, hypercholesterolemia, and hypertension.
  • Periodontitis severity increased with worsening glycaemic status. Severe periodontitis was apparent in:
    • 50.0% of participants with diabetes (75/150)
    • 37.2% of participants with IFG (123/331)
    • 26.7% of normoglycaemic individuals (415/1,555)
  • Inflammatory biomarkers such as CRP and WBC increased with both periodontitis severity and worsening glycaemic status, while PLR decreased. NLR showed no significant difference across glycaemic groups.
  • After adjustment, severe periodontitis was associated with higher odds of IFG or diabetes compared with no/mild periodontitis:
    • Diabetes: OR 2.4 (95% CI: 1.3–4.5; p = .006)
    • IFG: OR 1.6 (95% CI: 1.1–2.4; p = .023).
  • Each 1-mm increase in mean PD or CAL was associated with 90% and 40% higher odds of having diabetes, respectively. Moderate periodontitis was not significantly associated with IFG or diabetes after adjustment.
  • Separate mediation models estimated the following proportions of the association between severe periodontitis and glycaemic status mediated through each biomarker:
    • CRP: 5.2% for IFG and 8.1% for diabetes.
    • WBC: 19.1% for IFG and 12.6% for diabetes.
    • PLR: 7.1% for IFG and 6.4% for diabetes.

    These estimates should not be added together. NLR showed no significant mediation for either outcome.

  • None of the inflammatory biomarkers tested significantly modified the associations of periodontitis with IFG or diabetes.

Limitations

  • The cross-sectional design prevents assessment of causal relationships, making it unclear whether periodontitis causes diabetes or vice versa.
  • The diagnosis of IFG and diabetes was based on a single FPG measurement, potentially underestimating true prevalence.
  • Misclassification of diabetes types could also occur, though its impact is likely minor as type 1 diabetes constitutes a small proportion of cases.
  • CRP measurements were conducted on frozen serum a decade after collection (analysed in 2013 and collected in 2003), though research suggests CRP remains stable over time.
  • Residual confounding from unmeasured variables remains a possibility, even after adjusting for known risk factors.
  • Mediation percentages are estimates from statistical models, rather than proportions of diabetes or IFG cases caused by inflammation. The cross-sectional measurements cannot establish the temporal order required to confirm a causal pathway.

Conclusion

  • This study highlights a significant association between severe periodontitis, systemic inflammation, and worsening glycaemic status, including impaired fasting glucose and diabetes.
  • Mediation analysis suggests that systemic inflammation may partly explain these associations. However, the study could not establish their direction or demonstrate that periodontal treatment reduces diabetes risk.
Read the full article Back to Research

Research  |  03.03.18

clock icon 8 mins to read

Share this page:

Copy Link

You might also like...

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on…

Read more

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on the relationship between diabetes and oral health.

Read more
icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

Our Team

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Education & Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Outreach & Communications Lead

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Periodontitis-Diabetes Hub Position: Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Periodontitis-Diabetes Hub Position: Education and Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Periodontitis-Diabetes Hub Position: Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Periodontitis-Diabetes Hub Position: Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Periodontitis-Diabetes Hub Position: Outreach and Communications Lead

View All